Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

2861 - 2870 of 7311 results found

Characterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [14C]-labeled Microtracers with Separate Labeling Positions

Date
Friday, September 08, 2023 - 4:00 AM
Description
Pomotrelvir is an orally bioavailable, target antiviral inhibitor of the main protease (M^(pro)) of coronaviruses (CoVs), including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of Coronavirus Disease 2019 (COVID